1. Home
  2. AVR vs PMM Comparison

AVR vs PMM Comparison

Compare AVR & PMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVR
  • PMM
  • Stock Information
  • Founded
  • AVR 1999
  • PMM 1989
  • Country
  • AVR Australia
  • PMM United States
  • Employees
  • AVR N/A
  • PMM N/A
  • Industry
  • AVR
  • PMM Investment Managers
  • Sector
  • AVR
  • PMM Finance
  • Exchange
  • AVR NYSE
  • PMM Nasdaq
  • Market Cap
  • AVR 241.5M
  • PMM 261.3M
  • IPO Year
  • AVR 2024
  • PMM N/A
  • Fundamental
  • Price
  • AVR $3.25
  • PMM $5.82
  • Analyst Decision
  • AVR Strong Buy
  • PMM
  • Analyst Count
  • AVR 4
  • PMM 0
  • Target Price
  • AVR $16.50
  • PMM N/A
  • AVG Volume (30 Days)
  • AVR 317.0K
  • PMM 118.3K
  • Earning Date
  • AVR 05-16-2025
  • PMM 01-01-0001
  • Dividend Yield
  • AVR N/A
  • PMM 4.68%
  • EPS Growth
  • AVR N/A
  • PMM N/A
  • EPS
  • AVR N/A
  • PMM 0.23
  • Revenue
  • AVR $2,703,000.00
  • PMM N/A
  • Revenue This Year
  • AVR $29.52
  • PMM N/A
  • Revenue Next Year
  • AVR $204.83
  • PMM N/A
  • P/E Ratio
  • AVR N/A
  • PMM $26.52
  • Revenue Growth
  • AVR N/A
  • PMM N/A
  • 52 Week Low
  • AVR $2.34
  • PMM $5.00
  • 52 Week High
  • AVR $8.79
  • PMM $6.42
  • Technical
  • Relative Strength Index (RSI)
  • AVR N/A
  • PMM 38.36
  • Support Level
  • AVR N/A
  • PMM $5.75
  • Resistance Level
  • AVR N/A
  • PMM $5.91
  • Average True Range (ATR)
  • AVR 0.00
  • PMM 0.13
  • MACD
  • AVR 0.00
  • PMM -0.01
  • Stochastic Oscillator
  • AVR 0.00
  • PMM 26.36

About AVR ANTERIS TECHNOLOGIES GLOBAL CORP

Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

About PMM Putnam Managed Municipal Income Trust

Putnam Managed Municipal Income Trust is a closed-end management investment company. Its investment objective is to seek a high level of current income exempt from federal income tax by investing in a diversified portfolio of tax-exempt municipal securities. The Fund invests in various sectors such as healthcare, retirement community, private higher education, housing-backed, essential service utilities, and state-backed bonds.

Share on Social Networks: